Inspire Medical Systems, Inc.

INSP

Inspire Medical Systems, Inc.

INSP

Insider Sentiment (TTM):

Last Purchase:2025-04-07Last Sale:2026-05-15Shares Purchased (TTM):0Shares Sold (TTM):18,346

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:33,774,582Shares Outstanding:28,700,525Institutional Ownership Pct.:117.68%

Earnings Market Reaction:

Filing Date:2026-08-03Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	128	99	105	113	107	54	150	148	188	175	186	330
Short Term Investments	193	185	203	210	194	315	295	263	252	266	275	134
Accounts Receivable Net Current	103	105	120	108	138	93	93	90	80	72	90	71
Inventory Net	170	166	145	142	122	100	80	67	59	49	34	26
Prepaid Expense Current	14	12	10	14	13	10	12	14	29	10	10	8
Assets Current	609	567	584	586	573	572	631	583	607	572	594	570
Long Term Investments	94	116	96	88	110	45	71	113	26	28	9	3
Property Plant And Equipment Net	104	101	98	92	85	77	72	67	62	52	40	32
Operating Lease Right Of Use Asset	23	23	24	24	25	25	23	22	22	22	23	23
Deferred Income Tax Assets Net	78	88	89	-	-	-	0	-	-	-	-	-
Other Assets Noncurrent	18	17	17	17	9	12	11	11	11	11	11	12
Assets	926	911	907	808	802	731	808	796	728	686	677	639
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Trade Current	27	42	37	59	53	29	39	35	34	44	39	40
Accrued Liabilities Current	44	48	59	52	40	34	50	39	32	28	39	30
Liabilities Current	71	89	96	111	93	63	89	74	66	72	78	70
Operating Lease Liability Noncurrent	29	30	30	30	31	31	30	25	25	25	25	25
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	1	0
Liabilities	100	119	126	141	124	95	119	100	90	97	104	95
Stockholders Equity Inclu…
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	984	950	927	948	970	924	981	1,022	984	944	917	904
Accumulated Other Comprehensive Income Loss Net Of…	-1	-0	0	1	0	0	1	2	-0	0	1	0
Retained Earnings Accumulated Deficit	-157	-158	-146	-283	-293	-289	-292	-327	-346	-355	-345	-360
Stockholders Equity	826	792	781	666	678	636	690	697	638	589	573	544
Liabilities And Stockholders Equity	926	911	907	808	802	731	808	796	728	686	677	639
Allowance For Doubtful Accounts Receivable Current	1	1	1	1	1	1	1	1	1	0	2	1
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	29	29	29	29	30	29	30	30	30	30	30	29
Shares Outstanding	29	29	29	29	30	29	30	30	30	30	30	29

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-24.58%	-16.63%	-10.30%	-	-	-	-	-	-	-	-	-
2025	-12.94%	-16.59%	-18.82%	-27.90%	-40.56%	-40.35%	68.78%	29.52%	7.72%	5.40%	-7.98%	-5.12%
2024	-35.35%	-45.52%	-48.79%	22.32%	37.73%	32.78%	0.03%	-2.20%	-2.20%	1.27%	-21.58%	-11.70%
2023	-	-	-	-	-	-	-6.20%	25.78%	31.58%	-5.82%	10.22%	21.85%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.55	6.34	6.08	5.29	6.14	9.01	7.13	7.84	9.25	7.93	7.60	8.14
Quick Ratio	5.96	4.35	4.46	3.88	4.70	7.28	6.09	6.74	7.91	7.12	7.05	7.65
Working Capital	537.49M	477.40M	487.60M	475.65M	479.83M	508.21M	542.31M	508.26M	541.50M	500.04M	515.63M	499.60M
Leverage & Debt
Debt to Equity	0.12	0.15	0.16	0.21	0.18	0.15	0.17	0.14	0.14	0.16	0.18	0.18
Interest Coverage TTM	406.94	374.61	371.93	992.62	1,592.35	2,264.36	1,640.14	-	-	-	-	-
Debt Ratio	0.11	0.13	0.14	0.17	0.16	0.13	0.15	0.13	0.12	0.14	0.15	0.15
Efficiency & Turnover
Asset Turnover TTM	1.04	1.11	1.06	1.10	1.13	1.19	1.08	1.05	1.05	1.05	1.01	0.98
Days Sales Outstanding TTM	48.94	39.42	42.58	40.89	46.06	35.84	41.59	38.94	37.04	36.48	44.14	38.39
Receivables Turnover TTM	7.46	9.26	8.57	8.93	7.92	10.19	8.78	9.37	9.86	10.01	8.27	9.51
Per Share Metrics
Diluted EPS TTM	4.67	4.57	4.89	1.51	1.80	2.19	1.75	1.08	0.20	-0.53	-0.72	-1.12
Free Cash Flow Per Share TTM	3.39	3.37	2.67	3.88	3.39	2.65	3.06	1.28	-0.32	0.11	0.03	0.28
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	86.13%	85.78%	85.39%	84.92%	84.47%	84.65%	84.68%	84.77%	84.83%	84.65%	84.54%	84.10%
Operating Profit Margin TTM	6.02%	5.61%	5.59%	4.16%	4.81%	5.93%	4.49%	1.79%	-2.03%	-5.45%	-6.45%	-8.75%
Net Profit Margin TTM	15.03%	14.33%	15.95%	5.05%	6.17%	7.92%	6.67%	4.37%	0.85%	-2.38%	-3.39%	-5.75%
Growth Metrics
Net Revenue Growth (1Y)	4.35%	8.94%	13.60%	16.81%	22.05%	27.11%	28.49%	32.52%	34.14%	41.71%	53.19%	63.68%
Net Income Growth (1Y)	154.22%	97.18%	171.77%	34.82%	783.73%	-522.69%	-352.96%	-200.86%	-114.63%	-63.92%	-52.87%	-35.02%
EPS Growth (1Y)	160.14%	104.06%	175.42%	37.34%	790.38%	-521.45%	-349.04%	-199.13%	-114.39%	-64.56%	-54.85%	-37.54%
Valuation Metrics
P/E TTM	9.53	11.29	18.63	48.85	72.08	71.14	103.11	190.82	661.89	-404.29	-281.80	-177.85
P/B TTM	1.56	1.87	3.47	3.27	5.65	7.44	8.00	9.05	6.24	10.80	10.41	10.71
P/S TTM	1.43	1.62	2.97	2.47	4.45	5.63	6.87	8.35	5.64	9.62	9.54	10.22
Market Cap	1.29B	1.48B	2.71B	2.18B	3.83B	4.73B	5.52B	6.31B	3.98B	6.36B	5.96B	5.83B
Enterprise Value	1.16B	1.38B	2.60B	2.06B	3.72B	4.68B	5.37B	6.16B	3.79B	6.19B	5.78B	5.50B
Calculated Values
Free Cash Flow TTM	97.73M	96.71M	78.48M	113.93M	100.12M	78.85M	91.12M	38.20M	-9.42M	3.29M	1.02M	8.11M
Net Debt	-127.76M	-98.93M	-104.81M	-112.85M	-106.93M	-53.88M	-150.15M	-147.51M	-188.04M	-175.42M	-185.54M	-329.90M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-15Sale

Owner: Rondoni, John

Title: See Remarks

Shares: 2,641

Price/Share: $43.28

Value: $114,302.48

Shares Owned: 27,165

Relationship: Officer

Ownership: Direct

2026-05-14Sale

Owner: Rondoni, John

Title: See Remarks

Shares: 700

Price/Share: $43.01

Value: $30,107.00

Shares Owned: 29,806

Relationship: Officer

Ownership: Direct

2026-05-08Sale

Owner: Mccormick, Shawn

Title: -

Shares: 696

Price/Share: $45.31

Value: $31,535.76

Shares Owned: 27,712

Relationship: Director

Ownership: Direct

2026-01-09Sale

Owner: Rondoni, John

Title: See Remarks

Shares: 109

Price/Share: $100.00

Value: $10,900.00

Shares Owned: 13,797

Relationship: Officer

Ownership: Direct

2025-12-02Sale

Owner: Mccormick, Shawn

Title: -

Shares: 1,200

Price/Share: $139.00

Value: $166,800.00

Shares Owned: 24,846

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-15	Rondoni, John	Officer	See Remarks	Direct	Sale	2,641	43.28	$114,302.48	27,165	4
2026-05-14	Rondoni, John	Officer	See Remarks	Direct	Sale	700	43.01	$30,107.00	29,806	4
2026-05-08	Mccormick, Shawn	Director	-	Direct	Sale	696	45.31	$31,535.76	27,712	4
2026-01-09	Rondoni, John	Officer	See Remarks	Direct	Sale	109	100.00	$10,900.00	13,797	4
2025-12-02	Mccormick, Shawn	Director	-	Direct	Sale	1,200	139.00	$166,800.00	24,846	4
2025-11-28	Mccormick, Shawn	Director	-	Direct	Sale	2,000	127.48	$254,960.00	26,046	4
2025-08-29	Buchholz, Richard	Officer	Chief Financial Officer	Direct	Sale	11,000	93.39	$1,027,290.00	44,867	4
2025-08-08	Curet, Myriam	Director	-	Direct	Sale	4	77.28	$309.12	3,365	4
2025-05-19	Rondoni, John	Officer	See Remarks	Direct	Sale	1,734	149.38	$259,024.92	13,766	4
2025-05-02	Mccormick, Shawn	Director	-	Direct	Sale	360	160.00	$57,600.00	24,046	4
2025-04-07	Curet, Myriam	Director	-	Direct	Purchase	1	148.26	$148.26	3,371	4
2025-03-03	Rondoni, John	Officer	Chief Technology Officer	Direct	Sale	2,287	185.60	$424,467.20	15,500	4
2025-03-03	Ban, Randy	Officer	See Remarks	Direct	Sale	3,947	186.22	$735,010.34	7,259	4
2025-02-13	Ban, Randy	Officer	See Remarks	Direct	Sale	25,584	183.26	$4,688,523.84	7,259	4
2025-02-11	Rondoni, John	Officer	Chief Technology Officer	Direct	Sale	583	170.49	$99,395.67	10,424	4
2025-01-07	Rondoni, John	Officer	Chief Technology Officer	Direct	Sale	58	215.00	$12,470.00	11,322	4
2024-11-01	Rondoni, John	Officer	Chief Technology Officer	Direct	Sale	8,703	194.53	$1,692,994.59	11,348	4
2024-09-09	Rondoni, John	Officer	Chief Technology Officer	Direct	Sale	31	215.00	$6,665.00	11,348	4
2024-09-09	Mccormick, Shawn	Director	-	Direct	Sale	800	220.00	$176,000.00	23,140	4
2024-08-22	Rondoni, John	Officer	Chief Technology Officer	Direct	Sale	5,000	189.60	$948,000.00	11,379	4
2024-08-16	Ban, Randy	Officer	Chief Commercial Officer	Direct	Sale	4,861	188.47	$916,152.67	3,056	4
2024-04-17	Buchholz, Richard	Officer	Chief Financial Officer	Direct	Sale	15,000	230.03	$3,450,450.00	28,271	4
2024-04-01	Herbert, Timothy P.	Director,Officer	CEO and President	Indirect	Sale	40,000	207.60	$8,304,000.00	63,658	4/A
2024-04-01	Griffin, Jerry C	Director	-	Direct	Sale	32	213.99	$6,847.68	10,900	4
2024-03-25	Griffin, Jerry C	Director	-	Direct	Sale	554	197.81	$109,586.74	10,636	4
2024-03-22	Rondoni, John	Officer	Chief Technology Officer	Direct	Sale	4,387	194.46	$853,096.02	11,270	4
2024-03-18	Griffin, Jerry C	Director	-	Direct	Sale	554	193.53	$107,215.62	10,190	4
2024-03-11	Griffin, Jerry C	Director	-	Direct	Sale	554	198.05	$109,719.70	9,744	4
2024-03-01	Griffin, Jerry C	Director	-	Direct	Sale	554	179.44	$99,409.76	8,298	4
2024-02-29	Rondoni, John	Officer	Chief Technology Officer	Direct	Sale	8,605	179.61	$1,545,544.05	15,657	4
2024-02-27	Ban, Randy	Officer	Chief Commercial Officer	Direct	Sale	3,060	182.01	$556,950.60	3,029	4
2023-10-12	Sparks, Charisse Y	Officer	Chief Medical Officer	Direct	Purchase	100	153.50	$15,350.00	998	4
2023-09-08	Herbert, Timothy P.	Director,Officer	CEO and President	Indirect	Sale	47,992	-	-	106,651	4
2023-07-31	Griffin, Jerry C	Director	-	Direct	Sale	529	290.47	$153,658.63	8,852	4
2023-07-24	Griffin, Jerry C	Director	-	Direct	Sale	529	304.99	$161,339.71	8,381	4
2023-07-17	Griffin, Jerry C	Director	-	Direct	Sale	529	326.84	$172,898.36	7,910	4
2023-07-10	Griffin, Jerry C	Director	-	Direct	Sale	529	310.42	$164,212.18	7,439	4
2023-07-03	Griffin, Jerry C	Director	-	Direct	Sale	529	322.09	$170,385.61	6,968	4
2023-06-26	Griffin, Jerry C	Director	-	Direct	Sale	529	315.87	$167,095.23	6,497	4
2023-06-20	Griffin, Jerry C	Director	-	Direct	Sale	529	307.64	$162,741.56	6,026	4
2023-06-12	Griffin, Jerry C	Director	-	Direct	Sale	529	309.03	$163,476.87	5,555	4
2023-06-05	Griffin, Jerry C	Director	-	Direct	Sale	529	305.69	$161,710.01	5,084	4
2023-05-30	Griffin, Jerry C	Director	-	Direct	Sale	529	294.90	$156,002.10	4,613	4
2023-05-22	Griffin, Jerry C	Director	-	Direct	Sale	529	307.52	$162,678.08	4,142	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

117.68%

Inst. Shares: 33,774,582

Shares Outstanding: 28,700,525

2025-12-31

114.95%

Inst. Shares: 33,758,210

Shares Outstanding: 29,368,892

2025-09-30

104.63%

Inst. Shares: 30,690,960

Shares Outstanding: 29,332,376

2025-06-30

111.91%

Inst. Shares: 33,019,878

Shares Outstanding: 29,506,807

2025-03-31

111.85%

Inst. Shares: 33,223,237

Shares Outstanding: 29,702,358

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	33,774,582	28,700,525	117.68%
2025-12-31	33,758,210	29,368,892	114.95%
2025-09-30	30,690,960	29,332,376	104.63%
2025-06-30	33,019,878	29,506,807	111.91%
2025-03-31	33,223,237	29,702,358	111.85%
2024-12-31	32,430,981	29,763,395	108.96%
2024-09-30	31,978,058	29,879,621	107.02%
2024-06-30	30,395,599	29,728,849	102.24%
2024-03-31	30,203,147	29,615,166	101.99%
2023-12-31	29,792,832	29,302,154	101.67%
2023-09-30	26,762,035	29,365,968	91.13%
2023-06-30	25,547,847	29,229,922	87.40%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Inspire Medical Systems, Inc. (INSP) — SEC Financial Statements & Analysis

Inspire Medical Systems, Inc. (INSP) is a surgical & medical instruments & apparatus company, incorporated in DE. Inspire Medical Systems, Inc. trades on NYSE as: INSP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Inspire Medical Systems, Inc. reported a 4.35% year-over-year revenue growth, a Gross Profit Margin of 86.13% (TTM), a Debt-to-Equity ratio of 0.12x, a Price-to-Sales (P/S) ratio of 1.43x (TTM), a Price-to-Book (P/B) ratio of 1.56x (TTM), at a market cap of $1.29B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 4.35%
Gross Profit Margin TTM: 86.13%
Debt To Equity: 0.12x
P/S TTM: 1.43x
P/B TTM: 1.56x
Market Cap: $1.29B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Inspire Medical Systems, Inc. in?

Inspire Medical Systems, Inc. (INSP) operates in the Surgical & Medical Instruments & Apparatus industry.

What is INSP's market cap?

Inspire Medical Systems, Inc. (INSP) has a market capitalization of $1.29B as of 2026-06-30.

What is INSP's P/E ratio?

Inspire Medical Systems, Inc. (INSP)'s trailing twelve month P/E ratio is 9.53x as of 2026-06-30.

What exchange does INSP trade on?

Inspire Medical Systems, Inc. (INSP) trades on the NYSE.

Where is Inspire Medical Systems, Inc. incorporated?

Inspire Medical Systems, Inc. is incorporated in DE.